Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FREEPORT-MCMORAN INC Director's Dealing 2021

Nov 9, 2021

30000_dirs_2021-11-09_db730766-506c-40bd-bb12-08e8fb565a73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FREEPORT-MCMORAN INC (FCX)
CIK: 0000831259
Period of Report: 2021-11-08

Reporting Person: WHITMIRE C DONALD JR (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-08 Common Stock M 7500 $30.94 Acquired 67337 Direct
2021-11-08 Common Stock M 10000 $18.98 Acquired 77337 Direct
2021-11-08 Common Stock M 8500 $4.35 Acquired 85837 Direct
2021-11-08 Common Stock M 8500 $15.52 Acquired 94337 Direct
2021-11-08 Common Stock M 10000 $18.74 Acquired 104337 Direct
2021-11-08 Common Stock M 22500 $35.01 Acquired 126837 Direct
2021-11-08 Common Stock S 67000 $39.0996 Disposed 59837 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-08 Options (right to buy) $35.01 M 22500 Disposed 2023-01-29 Common Stock (22500) Direct
2021-11-08 Options (right to buy) $30.94 M 7500 Disposed 2024-02-04 Common Stock (7500) Direct
2021-11-08 Options (Right to Buy) $4.35 M 8500 Disposed 2026-02-02 Common Stock (8500) Direct
2021-11-08 Options (Right to Buy) $15.52 M 8500 Disposed 2027-02-07 Common Stock (8500) Direct
2021-11-08 Options (Right to Buy) $18.74 M 10000 Disposed 2028-02-06 Common Stock (10000) Direct
2021-11-08 Options (right to buy) $18.98 M 10000 Disposed 2025-02-03 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1959 Indirect
Common Stock 3785 Indirect
Common Stock 3785 Indirect

Footnotes

F1: Based on plan statement as of December 31, 2020.

F2: 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof.

F3: 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof.

F4: Amount beneficially owned following the reported transactions includes 44,999 Common Stock Restricted Stock Units.

F5: The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $39.0300 - $39.1750. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.